Media

News that truly makes a difference

Bullfrog AI.png
One giant leap for mankind.

We have reached the dawn of a new era in artificial intelligence and machine learning for preclinical and clinical therapeutics development. BullFrog AI is poised to join industry leaders at the forefront of this digital industrial revolution, by leveraging our proprietary bfLEAP™ AI/ML platform for precision development of new medicines. Therapies that will change peoples’ lives. Is there any greater purpose?

 

PRESS RELEASES:

 

April 21, 2022

The FSHD Society is deploying powerful AI technology to improve clinical trial design for facioscapulohumeral muscular dystrophy

March 22, 2022

BullFrog AI Enters into Licensing Agreement with Johns Hopkins University for Use of Novel Formulation of Mebendazole for Treatment of Cancer

May 21, 2020

BullFrog AI and TTi Health Research & Economics Announce Partnership

 

May 7, 2020

BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development

 

April 7, 2020

BullFrog AI Secures $200K from TEDCO’s Seed Fund

 

February 15, 2018

BullFrog AI Announces Strategic Partnership with The Lieber Institute for Brain Development to Improve Antipsychotic Drug Selection

 

October 20, 2017

Johns Hopkins Applied Physics Laboratory Licenses Big-Data Analysis Tool to BullFrog AI

Visual contents concept. Social networking service. Streaming video. Global communication
Medicine womsan doctor touching digital medical record tablet with DNA. AR of healthcare a